Display Info:
cookie.CK_ISO_CODE.value:us
cookie.CK_LANG_CODE.value:en
cookie.CK_DISPLAY_TYPE.value:
pageContext.request:org.apache.struts2.dispatcher.StrutsRequestWrapper@4f2cdb75
Request attributes: pageContext.request.scheme:http(not used)
syndicationProtocol:https
syndicationExtensionPrefix:.secure
syndicationDisplayType:
      LOADING ...

      System Message

      OKCancel

      ATP13A2 Polyclonal Antibody

      See 7 other ATP13A2 antibodies ›
      ATP13A2 Polyclonal Antibody for Western Blot and IHC

      Catalog#: PA1-16975 Invitrogen

      Catalog # Size Price (USD) Qty Datasheet
      PA1-16975 100 µL
      375.00
      Please enter a quantity in the range of 1 to 199.
      Suggested Secondary Antibodies

      Anti-Rabbit Secondary Antibodies (263)
      Alexa Fluor® Anti-Rabbit Secondary Antibodies (69)
      HRP Anti-Rabbit Secondary Antibodies (30)

      Product Details

      Bioinformatics

      Documents
      Details
      Tested species reactivity Human, Mouse
      Host / Isotype Rabbit / IgG
      Class Polyclonal
      Type Antibody
      Immunogen Synthetic peptide corresponding to residues 200-300 of human ATP13A2.
      Conjugate Unconjugated
      Form Liquid
      Concentration 0.75 mg/ml
      Purification Antigen affinity chromatography
      Storage buffer tris glycine with 150mM NaCl
      Contains 0.05% sodium azide
      Storage Conditions -20° C, Avoid Freeze/Thaw Cycles
      Tested Applications Dilution *
      Immunohistochemistry (IHC) 10 µg/ml
      Western Blot (WB) 2 µg/ml

      * Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.

      Product Specific Information

      Suggested positive control: human and mouse brain membrane prep lysate.

      Background/Target Information

      Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. ATP13A2 is a neuronal P-type ATPase gene underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia. ATP13A2 protein is located in the membrane of these lysosomes and is formed most strongly in the brain, especially in the substantia nigra, a brain region which is known to play a central role in Parkinson and quote;s disease.

      For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

      Bioinformatics

      Protein Aliases:

      AT132 antibody; ATPase type 13A2; Cation-transporting ATPase 13A2; HSA9947 antibody; probable cation-transporting ATPase 13A2

      Gene Aliases:

      1110012E06Rik; AA589443; ATP13A2; CLN12; HSA9947; KRPPD; PARK9

      UniProt ID:

      (Human) Q9NQ11, (Mouse) Q9CTG6

      Entrez Gene ID:

      (Human) 23400, (Mouse) 74772

      Molecular Function:

      cation transporter hydrolase ion channel transporter

      Function(s) Process(es)

      Documents

      Material safety data sheets (MSDS)

      Display Info:
      cookie.CK_ISO_CODE.value:us
      cookie.CK_LANG_CODE.value:en
      cookie.CK_DISPLAY_TYPE.value:
      pageContext.request.scheme:http(not used)
      syndicationProtocol:https
      syndicationExtensionPrefix:.secure
      syndicationDisplayType: